Human amnion epithelial cell therapy for bronchopulmonary dyspliasa

人羊膜上皮细胞治疗支气管肺发育不良

• 批准号: nhmrc : GNT1077769
• 负责人: A/Pr Graeme Polglase
• 金额: $ 100.87万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/human-amnion-epithelial-bronchopulmonary-dyspliasa/1345164
• 关键词: Human; amnion; epithelial; cell; therapy

Preterm infants, especially those born very early, commonly develop a type of chronic lung disease called bronchopulmonary displasia (BPD). There is currently no cure or means of preventing BPD. Cells from the amniotic membrane that surrounds the developing baby before birth show promise as a treatment, or perhaps even a way of preventing, BPD. This project will use a preterm lamb model of BPD to assess the ability of amnion cells to treat or prevent the disease.

早产儿，特别是那些出生非常早的婴儿，通常会患上一种称为支气管肺炎（BPD）的慢性肺部疾病。目前没有治愈或预防BPD的方法。出生前包裹在发育中的婴儿周围的羊膜细胞显示出治疗或甚至预防BPD的希望。该项目将使用BPD的早产羔羊模型来评估羊膜细胞治疗或预防疾病的能力。